Receptor Tyrosine Kinase Inhibitors [MoA] - N0000020000

Pharmacologic Class Information

Pharmacologic Code N0000020000
Pharmacologic Name Receptor Tyrosine Kinase Inhibitors
Pharmacologic Uses
  • kinase inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Receptor Tyrosine Kinase Inhibitors

The following table contains 12 products whose active ingredient are classified under the same pharmacologic class Receptor Tyrosine Kinase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0145Inlyta Non-Proprietary Name: AxitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-0151Inlyta Non-Proprietary Name: AxitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncACTIVE
0069-8140Xalkori Non-Proprietary Name: CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncACTIVE
0069-8141Xalkori Non-Proprietary Name: CrizotinibCapsuleOralPfizer Laboratories Div Pfizer IncACTIVE
0078-0698Rydapt Non-Proprietary Name: RydaptCapsule, Liquid FilledOralNovartis Pharmaceuticals CorporationACTIVE
62856-704Lenvima Non-Proprietary Name: LenvatinibCapsuleOralEisai Inc.ACTIVE
62856-708Lenvima Non-Proprietary Name: LenvatinibCapsuleOralEisai Inc.ACTIVE
62856-710Lenvima Non-Proprietary Name: LenvatinibCapsuleOralEisai Inc.ACTIVE
62856-712Lenvima Non-Proprietary Name: LenvatinibCapsuleOralEisai Inc.ACTIVE
62856-720Lenvima Non-Proprietary Name: LenvatinibCapsuleOralEisai Inc.ACTIVE
63539-026Inlyta Non-Proprietary Name: AxitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE
63539-044Inlyta Non-Proprietary Name: AxitinibTablet, Film CoatedOralU.s. PharmaceuticalsACTIVE